Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 14/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | GNPAT | O15228 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8084303 | 0.89 | NOD1 (0.49) | NOD1HDAC2SLC6A5CA2 | |
| SCHEMBL2167433 | 0.84 | FOLH1 (0.55) | NOD1SLC6A5CA2GNPAT | |
| SCHEMBL13301145 | 0.83 | FOLH1 (0.56) | NOD1GNPAT | |
| SCHEMBL13301142 | 0.83 | FOLH1 (0.52) | NOD1HDAC2 | |
| SCHEMBL15463082 | 0.82 | NOD1 (0.56) | NOD1HDAC2SLC6A5 | |
| SCHEMBL11736289 | 0.80 | NOD1 (0.58) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL11736294 | 0.80 | NOD1 (0.58) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL6668178 | 0.79 | NOD1 (0.62) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL9831561 | 0.79 | NOD1 (0.62) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL9831556 | 0.78 | NOD1 (0.75) | NOD1HDAC2SLC6A5GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1794117-A2 | MERCAPTOAMIDES AS HISTONE DEACETYLASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006028972-A2 | MERCAPTOAMIDES AS HISTONE DEACETYLASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2006-03-16 | — | — | WO | disclosed |